Hindustan Unilever (HUL) has announced two developments within its Health and Wellbeing (H&W) business, the full acquisition of Zywie Ventures Private Limited (OZiva) and the divestment of its 19.8% minority stake in Nutritionalab Private Limited. The transactions have been valued at Rs. 824 crores and Rs. 307 crores, respectively.
The company has entered the Health & Wellbeing category in 2023 and has focused on expanding its presence in the segment. OZiva has recorded growth following HUL’s earlier majority investment of 51%, reaching approximately Rs. 480 crores in 2025 and reporting around 130% CAGR over the past two years.
The Board of Directors of HUL has approved the acquisition of the remaining 49% stake in OZiva under a pre-agreed valuation framework, making the brand a wholly owned subsidiary of the company. The Board has also approved the sale of its 19.8% minority stake in Nutritionalab Private Limited to USV Private.
Both transactions have been expected to close by March 2026, subject to customary closing conditions.
Priya Nair, CEO and Managing Director, HUL, said, “Health & Wellbeing is an important growth vector for us, driven by rising consumer interest in everyday wellness. By taking full ownership of OZiva, we are doubling down on this exciting space to unlock the next phase of growth. Our decisions today reflect our intent of fewer, bigger bets where we can leverage HUL’s strengths in science, distribution and market development to scale purpose-led brands.”
